Alkermes plc Stock
Price
Target price
€22.40
€22.40
0.900%
0.2
0.900%
€34.08
22.04.24 / Stuttgart Stock Exchange
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Alkermes plc Stock
The Alkermes plc stock is trending slightly upwards today, with an increase of €0.20 (0.900%) compared to yesterday's price.
With 12 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 34 € there is a hugely positive potential of 51.79% for Alkermes plc compared to the current price of 22.4 €.
Pros and Cons of Alkermes plc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 0.900% | -0.893% | -11.905% | -15.267% | -11.200% | 28.324% | -25.000% |
| Icon plc | 0.680% | -0.604% | -9.008% | 48.790% | 8.240% | - | - |
| Novocure Ltd | 2.030% | -5.219% | -6.738% | -80.123% | -20.490% | -93.150% | - |
| Iovance Biotherapeutics Inc. | 4.420% | -4.917% | -23.544% | 99.307% | 36.206% | -58.970% | - |
Comments
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Jefferies Financial Group Inc. from $42.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $39.00 price target on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
News
Why Alkermes Stock Is Sinking Today
Shares of Alkermes (NASDAQ: ALKS) were sinking 7.9% as of 11:58 a.m. ET on Wednesday and had fallen as much as 13.1% earlier in the session. The decline came after the Ireland-based drugmaker
